Cite

HARVARD Citation

    Chanthavanich, P. et al. (2019). Safety, Tolerability and Immunogenicity of an MF59-adjuvanted, Cell Culture-derived, A/H5N1, Subunit Influenza Virus Vaccine. Pediatric infectious disease journal. 38 (7), p. . [Online]. 
  
Back to record